Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Nov;71(11):8841–8845. doi: 10.1128/jvi.71.11.8841-8845.1997

Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

D R Anderson 1, C M Carthy 1, J E Wilson 1, D Yang 1, D V Devine 1, B M McManus 1
PMCID: PMC192350  PMID: 9343244

Abstract

Innate immunity is central to the clearance of pathogens from hosts as well as to the definition of acquired immune responses (D. T. Fearon, and R. M. Locksley, Science 272:50-53, 1996). Coxsackievirus B3 (CVB3), a human cardiopathic virus, was evaluated for the ability to activate the alternative and classical pathway of complement. CVB3 proteins interact with complement component 3 (C3, a soluble protein effector of innate immunity) after either in vitro exposure to mouse serum or in vivo murine infection and activate the alternative pathway of complement. In addition, we demonstrate that viral antigen retention and localization in germinal centers is dependent on C3, while virus antigen retention in extrafollicular regions in the spleen is not. In vivo depletion of native C3 abolished the rapid formation of virus-specific germinal centers (by day 3 post-CVB3 infection) in the absence of serum anti-CVB3 antibodies. These studies demonstrate that innate immune mechanisms, such as C3 interaction with CVB3, are essential for splenic antiviral germinal center formation in naive (antigen nonsensitized) mice resistant (C57BL/6J strain) and susceptible (A/J strain) to CVB3-induced myocarditis.

Full Text

The Full Text of this article is available as a PDF (457.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996 Apr 5;272(5258):54–60. doi: 10.1126/science.272.5258.54. [DOI] [PubMed] [Google Scholar]
  2. Anderson D. R., Wilson J. E., Carthy C. M., Yang D., Kandolf R., McManus B. M. Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol. 1996 Jul;70(7):4632–4645. doi: 10.1128/jvi.70.7.4632-4645.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997 Feb 28;275(5304):1320–1323. doi: 10.1126/science.275.5304.1320. [DOI] [PubMed] [Google Scholar]
  4. Bergelson J. M., Mohanty J. G., Crowell R. L., St John N. F., Lublin D. M., Finberg R. W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol. 1995 Mar;69(3):1903–1906. doi: 10.1128/jvi.69.3.1903-1906.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boere W. A., Benaissa-Trouw B. J., Harmsen T., Erich T., Kraaijeveld C. A., Snippe H. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus. Immunology. 1986 Aug;58(4):553–559. [PMC free article] [PubMed] [Google Scholar]
  6. Boyer V., Delibrias C., Noraz N., Fischer E., Kazatchkine M. D., Desgranges C. Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand J Immunol. 1992 Dec;36(6):879–883. doi: 10.1111/j.1365-3083.1992.tb03150.x. [DOI] [PubMed] [Google Scholar]
  7. Boyer V., Desgranges C., Trabaud M. A., Fischer E., Kazatchkine M. D. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med. 1991 May 1;173(5):1151–1158. doi: 10.1084/jem.173.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cardosa M. J., Porterfield J. S., Gordon S. Complement receptor mediates enhanced flavivirus replication in macrophages. J Exp Med. 1983 Jul 1;158(1):258–263. doi: 10.1084/jem.158.1.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chow L. H., Beisel K. W., McManus B. M. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest. 1992 Jan;66(1):24–31. [PubMed] [Google Scholar]
  10. Cooper N. R. Complement evasion strategies of microorganisms. Immunol Today. 1991 Sep;12(9):327–331. doi: 10.1016/0167-5699(91)90010-Q. [DOI] [PubMed] [Google Scholar]
  11. Coyne K. E., Hall S. E., Thompson S., Arce M. A., Kinoshita T., Fujita T., Anstee D. J., Rosse W., Lublin D. M. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol. 1992 Nov 1;149(9):2906–2913. [PubMed] [Google Scholar]
  12. Crowell R. L., Field A. K., Schleif W. A., Long W. L., Colonno R. J., Mapoles J. E., Emini E. A. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J Virol. 1986 Feb;57(2):438–445. doi: 10.1128/jvi.57.2.438-445.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dempsey P. W., Allison M. E., Akkaraju S., Goodnow C. C., Fearon D. T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 1996 Jan 19;271(5247):348–350. doi: 10.1126/science.271.5247.348. [DOI] [PubMed] [Google Scholar]
  14. Devine D. V., Wong K., Serrano K., Chonn A., Cullis P. R. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta. 1994 Apr 20;1191(1):43–51. doi: 10.1016/0005-2736(94)90231-3. [DOI] [PubMed] [Google Scholar]
  15. Fearon D. T., Locksley R. M. The instructive role of innate immunity in the acquired immune response. Science. 1996 Apr 5;272(5258):50–53. doi: 10.1126/science.272.5258.50. [DOI] [PubMed] [Google Scholar]
  16. Hirsch R. L., Winkelstein J. A., Griffin D. E. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol. 1980 May;124(5):2507–2510. [PubMed] [Google Scholar]
  17. Klingel K., Stephan S., Sauter M., Zell R., McManus B. M., Bültmann B., Kandolf R. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol. 1996 Dec;70(12):8888–8895. doi: 10.1128/jvi.70.12.8888-8895.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Knowlton K. U., Jeon E. S., Berkley N., Wessely R., Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol. 1996 Nov;70(11):7811–7818. doi: 10.1128/jvi.70.11.7811-7818.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kosco M. H., Monfalcone A. P., Szakal A. K., Tew J. G. Germinal center B cells present antigen obtained in vivo to T cells in vitro and stimulate mixed lymphocyte reactions. Adv Exp Med Biol. 1988;237:883–888. doi: 10.1007/978-1-4684-5535-9_132. [DOI] [PubMed] [Google Scholar]
  20. Lederman S., Yellin M. J., Covey L. R., Cleary A. M., Callard R., Chess L. Non-antigen signals for B-cell growth and differentiation to antibody secretion. Curr Opin Immunol. 1993 Jun;5(3):439–444. doi: 10.1016/0952-7915(93)90066-2. [DOI] [PubMed] [Google Scholar]
  21. Lindberg A. M., Crowell R. L., Zell R., Kandolf R., Pettersson U. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 1992 Jul;24(2):187–196. doi: 10.1016/0168-1702(92)90006-u. [DOI] [PubMed] [Google Scholar]
  22. Liu Y. J., Zhang J., Lane P. J., Chan E. Y., MacLennan I. C. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol. 1991 Dec;21(12):2951–2962. doi: 10.1002/eji.1830211209. [DOI] [PubMed] [Google Scholar]
  23. Lodge P. A., Herzum M., Olszewski J., Huber S. A. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol. 1987 Sep;128(3):455–463. [PMC free article] [PubMed] [Google Scholar]
  24. MacLennan I. C., Liu Y. J., Johnson G. D. Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immunol Rev. 1992 Apr;126:143–161. doi: 10.1111/j.1600-065x.1992.tb00635.x. [DOI] [PubMed] [Google Scholar]
  25. Mapoles J. E., Krah D. L., Crowell R. L. Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol. 1985 Sep;55(3):560–566. doi: 10.1128/jvi.55.3.560-566.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McChesney M. B., Oldstone M. B. Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu Rev Immunol. 1987;5:279–304. doi: 10.1146/annurev.iy.05.040187.001431. [DOI] [PubMed] [Google Scholar]
  27. Montefiori D. C., Stewart K., Ahearn J. M., Zhou J., Zhou J. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J Virol. 1993 May;67(5):2699–2706. doi: 10.1128/jvi.67.5.2699-2706.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Oldstone M. B. Virus-lymphoid cell interactions. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12756–12758. doi: 10.1073/pnas.93.23.12756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pepys M. B. Role of complement in the induction of immunological responses. Transplant Rev. 1976;32:93–120. doi: 10.1111/j.1600-065x.1976.tb00230.x. [DOI] [PubMed] [Google Scholar]
  30. Prohászka Z., Hidvégi T., Ujhelyi E., Stoiber H., Dierich M. P., Süsal C., Füst G. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology. 1995 Jun;85(2):184–189. [PMC free article] [PubMed] [Google Scholar]
  31. Shafren D. R., Bates R. C., Agrez M. V., Herd R. L., Burns G. F., Barry R. D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol. 1995 Jun;69(6):3873–3877. doi: 10.1128/jvi.69.6.3873-3877.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Szakal A. K., Holmes K. L., Tew J. G. Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. J Immunol. 1983 Oct;131(4):1714–1727. [PubMed] [Google Scholar]
  33. Szakal A. K., Kosco M. H., Tew J. G. A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells. J Immunol. 1988 Jan 15;140(2):341–353. [PubMed] [Google Scholar]
  34. Szakal A. K., Taylor J. K., Smith J. P., Kosco M. H., Burton G. F., Tew J. J. Kinetics of germinal center development in lymph nodes of young and aging immune mice. Anat Rec. 1990 Aug;227(4):475–485. doi: 10.1002/ar.1092270411. [DOI] [PubMed] [Google Scholar]
  35. Tew J. G., Kosco M. H., Burton G. F., Szakal A. K. Follicular dendritic cells as accessory cells. Immunol Rev. 1990 Oct;117:185–211. doi: 10.1111/j.1600-065x.1990.tb00573.x. [DOI] [PubMed] [Google Scholar]
  36. Tew J. G., Kosco M. H., Szakal A. K. The alternative antigen pathway. Immunol Today. 1989 Jul;10(7):229–232. doi: 10.1016/0167-5699(89)90258-2. [DOI] [PubMed] [Google Scholar]
  37. Tomko R. P., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3352–3356. doi: 10.1073/pnas.94.7.3352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Vuorinen T., Vainionpä R., Kettinen H., Hyypiä T. Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines. Blood. 1994 Aug 1;84(3):823–829. [PubMed] [Google Scholar]
  39. Vuorinen T., Vainionpä R., Vanharanta R., Hyypiä T. Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection. J Virol. 1996 Dec;70(12):9018–9023. doi: 10.1128/jvi.70.12.9018-9023.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wolfgram L. J., Beisel K. W., Herskowitz A., Rose N. R. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol. 1986 Mar 1;136(5):1846–1852. [PubMed] [Google Scholar]
  41. de Verdugo U. R., Selinka H. C., Huber M., Kramer B., Kellermann J., Hofschneider P. H., Kandolf R. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol. 1995 Nov;69(11):6751–6757. doi: 10.1128/jvi.69.11.6751-6757.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. van Rooijen N. Antigen processing and presentation in vivo: the microenvironment as a crucial factor. Immunol Today. 1990 Dec;11(12):436–439. doi: 10.1016/0167-5699(90)90171-5. [DOI] [PubMed] [Google Scholar]
  43. van den Eertwegh A. J., Laman J. D., Schellekens M. M., Boersma W. J., Claassen E. Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited. Eur J Immunol. 1992 Mar;22(3):719–726. doi: 10.1002/eji.1830220315. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES